Frontage Holdings (SEHK:1521) Margin Rebound Reinforces Bullish Profit Recovery Narratives

Simply Wall St.

Mar 31

Frontage Holdings (SEHK:1521) has just posted its FY 2025 first half numbers, reporting revenue of US$126.6 million with basic EPS of US$0.0014, alongside trailing 12 month revenue of US$256.7 million...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2623584512"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2623584512\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2623584512?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","is_english":true,"pubTime":"2026-03-31 20:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2623584512","market":"nz","top_or_hot":-1,"title":"Frontage Holdings (SEHK:1521) Margin Rebound Reinforces Bullish Profit Recovery Narratives","media":"Simply Wall St.","content":"<div>\n<p>Frontage Holdings (SEHK:1521) has just posted its FY 2025 first half numbers, reporting revenue of US$126.6 million with basic EPS of US$0.0014, alongside trailing 12 month revenue of US$256.7 million...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1521/frontage-holdings-shares/news/frontage-holdings-sehk1521-margin-rebound-reinforces-bullish\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Frontage Holdings (SEHK:1521) Margin Rebound Reinforces Bullish Profit Recovery Narratives</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFrontage Holdings (SEHK:1521) Margin Rebound Reinforces Bullish Profit Recovery Narratives\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-31 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1521/frontage-holdings-shares/news/frontage-holdings-sehk1521-margin-rebound-reinforces-bullish><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Frontage Holdings (SEHK:1521) has just posted its FY 2025 first half numbers, reporting revenue of US$126.6 million with basic EPS of US$0.0014, alongside trailing 12 month revenue of US$256.7 million...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1521/frontage-holdings-shares/news/frontage-holdings-sehk1521-margin-rebound-reinforces-bullish\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4112","symbol_name":"金融交易所和数据","start_time":0,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1521/frontage-holdings-shares/news/frontage-holdings-sehk1521-margin-rebound-reinforces-bullish","article_id":"2623584512","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1521/frontage-holdings-shares/news/frontage-holdings-sehk1521-margin-rebound-reinforces-bullish","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2623584512","pubTimestamp":1774958969,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Frontage Holdings (SEHK:1521) has just posted its FY 2025 first half numbers, reporting revenue of US$126.6 million with basic EPS of US$0.0014, alongside trailing 12 month revenue of US$256.7 million and EPS of US$0.0034 that reflect a very large one year rebound in earnings and a net profit margin now at 2.6% compared with 0.3% a year earlier. Over recent reporting periods the company has seen revenue move from US$128.5 million and EPS of essentially breakeven in 2024 H1 to US$126.4 million...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4112":"金融交易所和数据","01521":"方达控股","BLSX":"Tradr 2X Long BLSH Daily ETF","BK1141":"生命科学工具和服务","BK1576":"医药外包概念","BK1583":"高瓴概念","BLSG":"2倍做多BLSH ETF-Leverage Shares"},"translate_title":"Frontage Holdings(SEHK：1521)利润率反弹强化了看涨的利润复苏叙事","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01521":1.98,"BLSX":0.6,"BLSG":0.6},"content_text":"Frontage Holdings (SEHK:1521) has just posted its FY 2025 first half numbers, reporting revenue of US$126.6 million with basic EPS of US$0.0014, alongside trailing 12 month revenue of US$256.7 million and EPS of US$0.0034 that reflect a very large one year rebound in earnings and a net profit margin now at 2.6% compared with 0.3% a year earlier. Over recent reporting periods the company has seen revenue move from US$128.5 million and EPS of essentially breakeven in 2024 H1 to US$126.4 million and EPS of US$0.0004 in 2024 H2, before reaching the latest US$126.6 million and US$0.0014 in 2025 H1, presenting a picture where gradually improving profitability is the key focus for investors watching margins. See our full analysis for Frontage Holdings. With the headline figures on the table, the next step is to set these earnings against the most widely held narratives around Frontage Holdings to see which views are supported by the numbers and which might need a rethink. Curious how numbers become stories that shape markets? Explore Community Narratives SEHK:1521 Revenue & Expenses Breakdown as at Mar 2026 AdvertisementTTM net income reaches US$6.8 million  On a trailing 12 month basis, net income was US$6.8 million on revenue of US$256.7 million, compared with US$0.8 million on US$254.9 million in the prior trailing period, while H1 2025 net income of US$2.9 million contrasts with a small loss in H1 2024. What stands out for a more bullish view is that this very large one year earnings rebound sits alongside a five year earnings trend that shows an annual decline of 31.5%. This means:\n     The recent TTM EPS of US$0.0034 builds on H1 2025 EPS of US$0.0014 after essentially breakeven H1 2024 results, yet longer term earnings have moved in the opposite direction on average. Supporters pointing to roughly 20% forecast annual earnings growth now have recent profit figures that align with that story, while the multi year decline keeps attention on how durable this rebound may be.    Curious how these mixed earnings trends shape the broader story for Frontage Holdings, and how other investors are framing it right now, Curious how numbers become stories that shape markets? Explore Community Narratives Margins at 2.6% alongside rich 41.9x P/E  The trailing net profit margin sits at 2.6% versus 0.3% a year earlier, while the shares change hands on a trailing P/E of 41.9x compared with a peer average of 27.1x and an Asian Life Sciences industry average of 35.2x. Critics highlight that a 41.9x P/E looks demanding against peers when profit margins remain low in absolute terms, and the recent profit rebound does not erase the five year earnings contraction. This means:\n     The move from 0.3% to 2.6% margin and TTM net income of US$6.8 million shows the business generating more profit, yet that profit still represents only a small slice of US$256.7 million in revenue. With earnings having fallen on average by 31.5% per year over five years, bears can point to the rich multiple as pricing in a smoother earnings path than the historical record shows.    DCF fair value HK$2.00 vs HK$1.10 price  The current share price of HK$1.10 sits well below a DCF fair value figure of HK$2.00, while forecasts point to revenue growth of about 7.6% per year and earnings growth of roughly 20% per year. Supporters argue that the gap between the HK$1.10 price and the HK$2.00 DCF fair value heavily supports a more bullish angle, yet the earnings record and growth mix keep the discussion nuanced, because:\n     The stock is described as trading about 45% below that DCF figure even after TTM EPS has moved to US$0.0034 and margins to 2.6%, which some investors view as the early stages of an earnings rebuild. At the same time, revenue growth expectations of 7.6% per year sit slightly below the 8.3% figure cited for the wider Hong Kong market, so any bullish case often leans more on profit recovery than on outpacing market level revenue growth.    Next Steps Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Frontage Holdings's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move. If this mix of optimism and caution has you undecided, review the numbers yourself and decide quickly where you stand by checking the 3 key rewards See What Else Is Out There Frontage Holdings pairs a rich 41.9x P/E and low 2.6% margin with a five year earnings trend that shows a 31.5% annual decline. If that mix of high valuation and patchy profit history feels uncomfortable, compare it with companies screened for stronger downside protection by checking the 262 resilient stocks with low risk scores  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}